Cart
sales@molnova.com
Benzenebutyric acid
CAS No. 1821-12-1
Benzenebutyric acid ( 4-Phenylbutyric acid )
Catalog No. M20554 CAS No. 1821-12-1
Benzenebutyric acid is an inhibitor of HDACand is an antineoplastic agent.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 500MG | 37 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBenzenebutyric acid
-
NoteResearch use only not for human use.
-
Brief DescriptionBenzenebutyric acid is an inhibitor of HDACand is an antineoplastic agent.
-
DescriptionBenzenebutyric acid is an inhibitor of HDACand is an antineoplastic agent.
-
Synonyms4-Phenylbutyric acid
-
PathwayCell Cycle/DNA Damage
-
TargetHDAC
-
RecptorHDAC
-
Research AreaMetabolic Disease
-
IndicationMaple Syrup Urine Disease
Chemical Information
-
CAS Number1821-12-1
-
Formula Weight164.2
-
Molecular FormulaC10H12O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:125 mg/mL (761.27 mM)
-
SMILESOC(=O)CCCc1ccccc1
-
Chemical Name4-Phenylbutyric acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Tsg-Hui C Eva S . Enhanced growth inhibition by combination differentiation therapy with ligands of peroxisome proliferator-activated receptor-gamma and inhibitors of histone deacetylase in adenocarcinoma of the lung[J]. Clinical Cancer Research 2002 8(4):1206-1212.
molnova catalog
related products
-
HDAC1,2-IN-2
A potent, selective HDAC1 and HDAC2 inhibitor with IC50 of 6 nM and 45 nM, respectively.
-
SALL4 peptide FFW
SALL4 peptide FFW (RRKFAKFQWI, FFW peptide) is a potent therapeutic SALL4 peptide antagonist of SALL4-NURD.
-
SS-208
SS-208 is a selective inhibitor of HDAC6 (IC50 = 12 nM) with anti-tumor activity. SS-208 shows selectivity over other HDAC subtypes.
